Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


M&A Analysis: Philips Inks Trio Of Deals As Activity Levels Heat Up

Executive Summary

It was a hot month for medtech M&A activity, with a total of 21 deals announced and closed in June. Dutch giant Philips continued its mission to grow its health-care business and inked three acquisitions, including a $2bn deal to buy vascular imaging business Spectranetics.

You may also be interested in...

Philips Persists With M&A Strategy; Snaps Up Ultrasound Dx Biz

Philips is strengthening its hand in cardiac ultrasound with the addition of German ultrasound firm TomTec Imaging Systems, its seventh acquisition of the year. Financial terms of the deal were not disclosed.

Philips Keeps The Pace With More Portfolio Shuffling

Philips continues its product-portfolio restructure with the acquisition of CardioProlific, a developer of catheter-based thrombectomy devices, and the divestiture of its Sonalleve MR-HIFU business to Profound Medical. The transactions were announced the same week Philips cut a $2bn deal for Spectranetics.

Philips Grows Image-Guided Intervention Focus With Spectranetics Buy

In its second acquisition this month and fourth this year, Philips is buying US device maker Spectranetics Corp. for about $2bn to add laser atherectomy catheters to its vascular imaging line-up.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts